Podcast with Dr. Fatima Cardoso about the results of the phase 3 KEYNOTE-756 trial: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant endocrine therapy and pembrolizumab in early-stage ER+/HER2- breast cancer Back to previous page